BioNano Genomics Inc vs Kroger Co — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Kroger Co trades at $56.08 (market cap $34.46B). The key difference: Kroger Co is far larger — about 2522.7× BioNano Genomics Inc's market cap, and Kroger Co pays a 2.56% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | KR | |
|---|---|---|
Market Cap | $13.66M | $34.46B |
Sector | Health | Consumer Staples |
52-Week High | $4.92 | $75.60 |
52-Week Low | $1.06 | $55.53 |
Enterprise Value | $16.26M | $54.56B |
Dividend Yield | — | 2.56% |
Trailing returns across standard periods
Latest headlines on both assets
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →